MarketPulse

emerging therapies

7 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Hepatic Encephalopathy Market Poised for Steady Growth as New Therapies Address Rising Disease Burden

Hepatic encephalopathy market projected to grow 1.2% annually through 2036, reaching $900M in 2025, driven by emerging therapies and increased diagnosis awareness.
GRFSBHCclinical trialsmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Peripheral T-Cell Lymphoma Market Set to Expand 7% Annually Through 2036

PTCL market valued at USD 800 million in 2025 to grow 7% annually through 2036, driven by emerging therapies and rising disease incidence. U.S. represents 68% of market.
BMYCELGrMRKPFEIPHA+3FDA approvalclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

US Eosinophilic Esophagitis Market Poised for Explosive Growth as Novel Drug Classes Emerge

US eosinophilic esophagitis market valued at $647M in 2025 projected to grow 13.2% annually through 2036, driven by novel drug classes and improved diagnostics.
AMGNSNYAZNREGNEPRX+3market growthpharmaceutical pipeline
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Alpha Thalassemia Market Set for Robust Growth Through 2036 on Gene Therapy Advances

Alpha thalassemia market poised for significant expansion driven by rising prevalence, diagnostic advances, and pipeline therapies from $AGIOS and $NVO through 2036.
BMYCELGrNVOAGIOclinical trialsgene therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Interstitial Lung Disease Market Set to Surge 8.7% Annually Through 2036

Interstitial lung disease market valued at $6B in 2025 expected to grow 8.7% annually through 2036, driven by FDA-approved therapies and emerging pipeline candidates.
BMYCELGrRHHBYGSKUTHR+5FDA approvalclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Idiopathic Membranous Nephropathy Market Poised to Hit $1B by 2036

IMN market expected to grow nearly 8x from $130M in 2025 to $1B by 2036, driven by novel therapies addressing unmet treatment needs.
NKTXVRTXRHHBYAZNBIIB+2clinical trialspharmaceutical pipeline
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Spinal Cord Injury Market Set to Quadruple as Six Therapies Challenge Treatment Void

Spinal cord injury market projected to grow from $354M to $1.4B by 2034 as six emerging therapies target previously untreated condition.
ABBVNGENclinical trialsmarket growth